Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
USD | Fiscal Year Ending | | Latest |
(in millions) | Dec-15 | Dec-16 | Dec-17 | Dec-18 | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | Dec-24 | | Dec-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 1,741 | 1,387 | 1,195 | 1,063 | 1,123 | 961 | 1,050 | 954 | 1,067 | 976 | | 976 |
% Growth | NA | -20.3% | -13.9% | -11.0% | 5.7% | -14.5% | 9.3% | -9.2% | 11.8% | -8.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | (327) | (189) | (141) | (131) | (109) | (77) | (114) | (65) | (57) | (52) | | (52) |
Gross Profit | 1,414 | 1,198 | 1,053 | 932 | 1,014 | 884 | 937 | 889 | 1,009 | 924 | | 924 |
% Revenue | 81.2% | 86.4% | 88.2% | 87.6% | 90.3% | 92.0% | 89.2% | 93.2% | 94.6% | 94.6% | | 94.6% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | (7) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
General and Admin | (959) | (877) | (755) | (596) | (563) | (479) | (472) | (466) | (336) | (369) | | (369) |
Other Inc / (Exp) | (121) | (134) | (324) | (318) | (480) | (417) | (351) | (258) | (536) | (320) | | (320) |
Total Operating Exp | (1,080) | (1,011) | (1,086) | (914) | (1,044) | (896) | (823) | (724) | (872) | (689) | | (689) |
| | | | | | | | | | | | |
Operating Income | 334 | 187 | (33) | 18 | (29) | (12) | 113 | 165 | 138 | 235 | | 235 |
% Revenue | 19.2% | 13.5% | -2.8% | 1.7% | -2.6% | -1.3% | 10.8% | 17.3% | 12.9% | 24.1% | | 24.1% |
| | | | | | | | | | | | |
Interest Expense | (464) | (394) | (111) | (89) | (97) | (93) | (118) | (140) | (196) | (196) | | (196) |
Pre-tax Income | (130) | (206) | (144) | (71) | (126) | (106) | (4) | 25 | (58) | 39 | | 39 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (117) | 7 | 16 | (1) | (16) | 66 | 22 | 1 | (6) | (5) | | (5) |
Net Income to Company | (247) | (199) | (128) | (71) | (142) | (40) | 18 | 26 | (64) | 34 | | 34 |
% Margin | -14.2% | -14.4% | -10.8% | -6.6% | -12.7% | -4.2% | 1.7% | 2.7% | -6.0% | 3.5% | | 3.5% |
| | | | | | | | | | | | |
Minority Interest in Earnings | (0) | (0) | 0 | (0) | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (247) | (200) | (128) | (71) | (142) | (40) | 18 | 26 | (64) | 34 | | 34 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (1) | | (1) |
Other Adj. | 0 | 0 | 0 | (1) | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (247) | (200) | (128) | (72) | (142) | (40) | 18 | 26 | (64) | 33 | | 33 |
% Margin | -14.2% | -14.4% | -10.7% | -6.8% | -12.7% | -4.2% | 1.7% | 2.7% | -6.0% | 3.4% | | 3.4% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (29.57) | (24.17) | (15.10) | (8.10) | (15.86) | (4.59) | 2.01 | 2.97 | (8.34) | 4.27 | | 4.27 |
Diluted EPS (Continuing Ops) | (29.57) | (24.17) | (15.15) | (8.10) | (15.86) | (4.59) | 1.93 | 2.85 | (8.34) | 4.13 | | 4.13 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 8.35 | 8.27 | 8.47 | 8.91 | 8.96 | 8.75 | 9.02 | 8.65 | 7.64 | 7.82 | | 7.82 |
WA Diluted Shares Out. | 8.35 | 8.27 | 8.47 | 8.91 | 8.96 | 8.75 | 9.38 | 9.00 | 7.64 | 8.09 | | 8.09 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (130) | (206) | (144) | (71) | (126) | (106) | (4) | 25 | (58) | 39 | | 39 |
Addback: Net Interest Expense | 464 | 394 | 111 | 89 | 97 | 93 | 118 | 140 | 196 | 196 | | 196 |
Addback: Other Non Operating Expenses, Total | 6 | 98 | 296 | 330 | 484 | 397 | 312 | 257 | 518 | 255 | | 255 |
Addback: Depreciation & Amortization | 118 | 58 | 79 | 27 | 32 | 16 | 11 | 15 | 12 | 8 | | 8 |
Addback: Restructuring Charges | 0 | 0 | 7 | 12 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 14 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (84) | (8) | (11) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Asset Writedown | 17 | 11 | (3) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (28) | 0 | 0 | | 0 |
Addback: Other Unusual Items | 7 | 0 | 0 | (64) | (5) | 0 | 16 | (1) | (1) | 49 | | 49 |
Adjusted EBITDA | 399 | 346 | 334 | 337 | 481 | 401 | 452 | 409 | 667 | 548 | | 548 |
% Margin | 22.9% | 25.0% | 28.0% | 31.7% | 42.8% | 41.7% | 43.0% | 42.8% | 62.5% | 56.1% | | 56.1% |
| | | | | | | | | | | | |
Adjusted EBIT | 280 | 288 | 256 | 310 | 449 | 385 | 441 | 394 | 655 | 540 | | 540 |
% Margin | 16.1% | 20.8% | 21.4% | 29.1% | 40.0% | 40.1% | 42.0% | 41.3% | 61.4% | 55.3% | | 55.3% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (247) | (199) | (128) | (71) | (142) | (40) | 18 | 26 | (64) | 34 | | 34 |
Addback: Unusual Items | (60) | 2 | (7) | (38) | (5) | 0 | 16 | (29) | (1) | 49 | | 49 |
Less: Tax Benefit of Unusual Items (26%) | 15 | (1) | 2 | 10 | 1 | 0 | (4) | 7 | 0 | (13) | | (13) |
Adjusted Net Income | (291) | (198) | (134) | (99) | (146) | (40) | 30 | 5 | (65) | 70 | | 70 |
% Margin | -16.7% | -14.2% | -11.2% | -9.3% | -13.0% | -4.2% | 2.8% | 0.5% | -6.1% | 7.2% | | 7.2% |